Name Symbol Market Type
Merck KGaA (PK) USOTC:MKKGY OTCMarkets Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.0% 29.35 28.83 29.17 0.00 12:47:11

Merck KGaA Confirms 2020 Outlook; Prioritizes Lower Debt

16/09/2020 7:59am

Dow Jones News

Historical Stock Chart

From Aug 2020 to Sep 2020

Click Here for more Merck KGaA (PK) Charts.
   By Kim Richters 

Merck KGaA on Wednesday backed its outlook for the full year, and said it is currently focusing on organic growth and lowering its debt.

The pharmaceuticals and chemicals company continues to expect slight to moderate organic growth in full-year net sales and Ebitda pre, or earnings before interest, taxes, depreciation and amortization before one-time items.

This equates to sales of 16.9 billion to 17.7 billion euros ($20.02 billion-$20.97 billion) and Ebitda pre of EUR4.45 billion to EUR4.85 billion.

As for its health-care core business, Merck confirmed its target of around EUR2 billion in own pipeline sales by 2022.

For its life-science business, Merck forecasts 6% to 9% average yearly organic sales growth in the medium term.

The company said it is currently prioritizing organic growth and lowering its debt until 2022.

While it won't rule out "large transformative deals" from 2022 onward, Merck said it is likelier to make "a number of smaller to medium-sized acquisitions."


Write to Kim Richters at


(END) Dow Jones Newswires

September 16, 2020 02:44 ET (06:44 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Merck KGaA (PK) Chart

1 Year Merck KGaA (PK) Chart

1 Month Merck KGaA (PK) Chart

1 Month Merck KGaA (PK) Chart
ADVFN Advertorial
Your Recent History
Merck KGaA..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200922 12:02:20